Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Surg Res. 2014 May 27;191(1):33–41. doi: 10.1016/j.jss.2014.05.051

Figure 3.

Figure 3

Changes in cell proliferation in wire-injured femoral vessels from the control B6 (A), diabetic (NOD) (B) and metabolic syndrome (RCS-10) (C) groups. Labeling of proliferating VSMC in specimens is performed using the thymidine analogue 5-bromo-2′-deoxyuridine (BrdU). Values are the mean± s.e.m. proportion of positive cells (n=6 per group). D and E show representational cross-sections of the uninjured vessel in the left panel (D) and an injured vessel in the right panel (E) which also has an inlay demonstrating a positively stained cell. Statistical differences between groups were tested with a Kruskal-Wallis non-parametric test with post hoc Dunn’s multiple comparison correction, where appropriate.